Brief: Organogenesis Q4 Revenue USD 126.7 Million
27/02/2025 21:05
Feb 27 (Reuters) - Organogenesis Q4 operating income USD 10.2 million. Q4 adjusted net income USD 8.8 million Q4 net income USD 7.7 million Q4 adjusted EBITDA USD 18.2 million outlook FY EBITDA USD 27-66.6 million outlook FY adjusted EBITDA USD 43.6-83.2 million
Recent news on Organogenesis Holdings
See all newsBrief: Organogenesis Announces Publication Of Peer-Reviewed Prepare Trial Results
Organogenesis Holdings Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Organogenesis Q2 Net Product Revenue USD 42.8 Million
Organogenesis Holdings Inc. expected to post a loss of 35 cents a share - Earnings Preview
Brief: Organogenesis Announces Publication Of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit Of Affinity™ In The Most Challenging And Complex Venous Leg Ulcers